Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts.
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Type I carbohydrate-deficient glycoprotein syndrome (CDGS) patients fail to add entire N-linked oligosaccharide chains to some serum glycoproteins.Here we show that four CDGS fibroblast cell lines have two related glycosylation abnormalities.First, they incorporate 3-10-fold less [ 3 H] mannose into proteins, and, second, the size of the lipid-linked oligosaccharide precursor (LLO) is much smaller than in controls.Addition of exogenous mannose, but not glucose, to these CDGS cells corrects both the lowered [ 3 H]mannose incorporation and the size of LLO.These corrections are not permanent, and the defects immediately reappear when mannose is removed.To explore further the basis of mannose correction, we analyzed the amount of 3 H-labeled LLO intermediates.Except for dolichol-P-mannose, other precursors, including mannose, mannose-6-phosphate, mannose-1-phosphate, and GDP-mannose, all showed a 3-10fold decrease in CDGS cells.Thus, there are no obvious lesions in the intracellular conversion of mannose into LLO, and, once inside the cell, [ 3 H]mannose appeared to be metabolized normally.Initial velocities of [ 3 H] mannose uptake were two-to threefold less in CDGS cells compared with controls, and this slower transport may partially explain the reduced [ 3 H]mannose incorporation in CDGS cells.Since we previously showed that the enzymes converting glucose to mannose-6-phosphate appear to be normal, our results suggest that cells may acquire or generate mannose in other ways.Although we have not identified the primary defect in CDGS, these studies show that intracellular mannose is limited and that some patients might benefit from including mannose in their regular diets.( J. Clin.Invest.1996.97:1478-1487.)Key words: glycosylation • lipidlinked oligosaccharide • glycoprotein • hexose transporter • CDG syndrome Methods Materials.Most of the materials were obtained from Sigma Chemical Co.(St.Louis, MO), except for the following: concanavalin A (Con A)-Sepharose (Pharmacia Fine Chemicals, Piscataway, NJ), ␣ -MEM (GIBCO BRL, Baltimore, MD), FBS (Hyclone Laboratories, Logan, UT), Micropak AX-5 HPLC column (Varian Instruments, Walnut Creek, CA), and microspin filters (Lida Manufacturing Corp., Kenosha, WI).Radiolabels.2-[ 3 H]Mannose (15 Ci/mmol), 2-deoxy[1,2-3 H(N)]glucose (40 Ci/mmol), and [ 35 S]methionine (1,217 Ci/mmol) were obtained from American Radiolabeled Chemicals, Inc. (St. Louis, MO).Cell lines.The CDGS and control cell lines were all obtained from Dr. Neil Buist (Department of Pediatrics, Oregon Health Sciences University, Portland, OR).CDGS 1 and 2, our designation, are patients from the same family (samples F27467 and F27468) described in our previous study (13).CDGS cell lines 3 and 4 are patients from another family (samples F20660 and F02661, coded by Dr. N. Buist).All these patients are diagnosed as type I CDGS based on the clinical and biochemical (transferrin pattern) analyses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSEMBLY OF ASPARAGINE-LINKED OLIGOSACCHARIDES
Kornfeld, R., & Kornfeld, S. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.003215 · Cited by 4,906
Facilitated diffusion of glucose
Carruthers, A. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.4.1135 · Cited by 361
Gould, G. W., Thomas, H. M., Jess, T. J., & Bell, G. I. (1991) · Biochemistry · doi:10.1021/bi00235a004 · Cited by 303
Jaeken, J., van Eijk, H. G., van der Heul, C., Corbeel, L., Eeckels, R., & Eggermont, E. (1984) · Clinica Chimica Acta · doi:10.1016/0009-8981(84)90059-7 · Cited by 280 · cited 1×
“All patients show altered isoelectric focusing patterns of multiple serum glycoproteins that result from undersialylation of their N-linked oligosaccharides (3, 4).”
BackgroundEnvironmental Effects on Protein Glycosylation
Goochee, C. F., & Monica, T. (1990) · Nature Biotechnology · doi:10.1038/nbt0590-421 · Cited by 247
Chapman, A., Fujimoto, K., & Kornfeld, S. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85510-2 · Cited by 233
Assembly of Asparagine-Linked Oligosaccharides
Kornfeld, R. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.54.1.631 · Cited by 215
Jaeken, J., Schachter, H., Carchon, H., De Cock, P., Coddeville, B., & Spik, G. (1994) · Archives of Disease in Childhood · doi:10.1136/adc.71.2.123 · Cited by 193
The role of N-glycosylation of GLUT1 for glucose transport activity.
Asano, T., Katagiri, H., Takata, K., Lin, J. L., Ishihara, H., Inukai, K., Tsukuda, K., Kikuchi, M., Hirano, H., & Yazaki, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54276-9 · Cited by 187
Jaeken, J., Stibler, H., & Hagberg, B. A. (1991) · PubMed · Cited by 187
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
Niehues, R., Hasilik, M., Alton, G., Körner, C., Schiebe-Sukumar, M., Koch, H. G., Zimmer, K. P., Wu, R., Harms, E., Reiter, K., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2350 · Cited by 422
“Based on studies showing that mannose could correct abnormal glycosylation in CDGS type Ia fibroblasts (15), mannose therapy was initiated and followed up for 11 mo.”
BackgroundSelf-citationMarquardt, T., & Denecke, J. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-002-1136-0 · Cited by 290
Altered glycan structures: the molecular basis of congenital disorders of glycosylation
Freeze, H. H., & Aebi, M. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.08.010 · Cited by 250
Self-citationCongenital disorders of glycosylation
Chang, I. J., He, M., & Lam, C. T. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.10.45 · Cited by 235
Perspectives on Glycosylation and Its Congenital Disorders
Ng, B. G., & Freeze, H. H. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.03.002 · Cited by 228
Self-citationde Lonlay, P., Seta, N., Barrot, S., Chabrol, B., Drouin, V, Gabriel, B. M., Journel, H., Kretz, M., Laurent, J., Le Merrer, M., et al. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.1.14 · Cited by 220
Congenital Disorders of Glycosylation
Patterson, M. C. (2017) · Oxford Medicine Online · doi:10.1093/med/9780199937837.003.0066 · Cited by 210
Neurology of inherited glycosylation disorders
Freeze, H. H., Eklund, E. A., Ng, B. G., & Patterson, M. C. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70040-6 · Cited by 201
Self-citationChui, D., Oh-Eda, M., Liao, Y.-F., Panneerselvam, K., Lal, A., Marek, K. W., Freeze, H. H., Moremen, K. W., Fukuda, M. N., & Marth, J. D. (1997) · Cell · doi:10.1016/s0092-8674(00)80322-0 · Cited by 198
Self-citationGlycoproteins and Their Relationship to Human Disease
Brockhausen, I., Schutzbach, J., & Kuhns, W. (1998) · Cells Tissues Organs · doi:10.1159/000046450 · Cited by 190
Congenital Disorders of Glycosylation
Jaeken, J., & Matthijs, G. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.129 · Cited by 189
Haeuptle, M. A., & Hennet, T. (2009) · Human Mutation · doi:10.1002/humu.21126 · Cited by 185
Kim, S., Westphal, V., Srikrishna, G., Mehta, D. P., Peterson, S., Filiano, J., Karnes, P. S., Patterson, M. C., & Freeze, H. H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7302 · Cited by 177
Self-citationCongenital disorders of glycosylation (CDG): It's all in it!
Jaeken, J. (2003) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1024431131208 · Cited by 177
Imbach, T., Schenk, B., Schollen, E., Burda, P., Stutz, A., Grünewald, S., Bailie, N. M., King, M. D., Jaeken, J., Matthijs, G., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8691 · Cited by 176
Lee, S., Zhang, C., Kilicarslan, M., Piening, B. D., Bjornson, E., Hallström, B. M., Groen, A. K., Ferrannini, E., Laakso, M., Snyder, M., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.026 · Cited by 163
“Alterations in mannose metabolism may affect glycoprotein synthesis and secretion since mannose is the main source of glycoprotein synthesis (Panneerselvam et al., 1997; Panneerselvam and Freeze, 1996).”
Kurtoglu, M., Maher, J. C., & Lampidis, T. J. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1714 · Cited by 163
Direct utilization of mannose for mammalian glycoprotein biosynthesis
Alton, G., Hasilik, M., Niehues, R., Panneerselvam, K., Etchison, J. R., Fana, F., & Freeze, H. H. (1998) · Glycobiology · doi:10.1093/glycob/8.3.285 · Cited by 157
Self-citationUpdate and perspectives on congenital disorders of glycosylation
Freeze, H. H. (2001) · Glycobiology · doi:10.1093/glycob/11.12.129r · Cited by 156
“Mannose presumably enters the cells through the mannose-specific transporter (Ogier-Denis et al., 1990, 1994; Panneerselvam and Freeze, 1996b; Panneerselvam et al., 1997).”
BackgroundSelf-citationWu, X., Rush, J. S., Karaoglu, D., Krasnewich, D. M., Lubinsky, M., Waechter, C. J., Gilmore, R., & Freeze, H. H. (2003) · Human Mutation · doi:10.1002/humu.10239 · Cited by 152
Self-citationde Lonlay, P., & Séta, N. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.11.012 · Cited by 134
Congenital disorders of glycosylation
Jaeken, J. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59565-2.00044-7 · Cited by 122
CDG Therapies: From Bench to Bedside
Brasil, S., Pascoal, C., Francisco, R., Marques‐da‐Silva, D., Andreotti, G., Videira, P. A., Morava, É., Jaeken, J., & Ferreira, V. D. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051304 · Cited by 117
Glycosylation diseases: Quo vadis?
Schachter, H., & Freeze, H. H. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.11.002 · Cited by 111
Self-citationAlton, G., Kjærgaard, S., Etchison, J. R., Skovby, F., & Freeze, H. H. (1997) · Biochemical and Molecular Medicine · doi:10.1006/bmme.1997.2574 · Cited by 111
Self-citationRecognizable phenotypes in CDG
Ferreira, C. R., Altassan, R., Marques‐da‐Silva, D., Francisco, R., Jaeken, J., & Morava, É. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-018-0156-5 · Cited by 109
Carbohydrate-deficient Glycoprotein Syndrome
Krasnewich, D., & Gahl, W. A. (1997) · Advances in Pediatrics · doi:10.1016/s0065-3101(24)00050-1 · Cited by 101
Grubenmann, C. E., Frank, C. G., Hülsmeier, A. J., Schollen, E., Matthijs, G., Mayatepek, E., Berger, E. G., Aebi, M., & Hennet, T. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh050 · Cited by 101
Burda, P., Borsig, L., de Rijk-van Andel, J., Wevers, R., Jaeken, J., Carchon, H., Berger, E. G., & Aebi, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2266 · Cited by 98
Harms, H. K., Zimmer, K., Kurnik, K., Bertele‐Harms, R. M., Weidinger, S., & Reiter, K. (2002) · Acta Paediatrica · doi:10.1080/080352502760311566 · Cited by 93
Targeted Disruption of the Mouse Phosphomannomutase 2 Gene Causes Early Embryonic Lethality
Thiel, C., Lübke, T., Matthijs, G., FIGURA, K. V., & Körner, C. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02391-05 · Cited by 93
Protein glycosylation in disease: new insights into the congenital muscular dystrophies
Martin‐Rendon, E., & Blake, D. J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00050-6 · Cited by 90
Mannose Enters Mammalian Cells Using a Specific Transporter That Is Insensitive to Glucose
Panneerselvam, K., & Freeze, H. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9417 · Cited by 89
Self-citationSuccessful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice
Schneider, A., Thiel, C., Rindermann, J., DeRossi, C., Popovici, D., Hoffmann, G. F., Gröne, H., & Körner, C. (2011) · Nature Medicine · doi:10.1038/nm.2548 · Cited by 89
Disorders in protein glycosylation and potential therapy: Tip of an iceberg?
Freeze, H. H. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70096-4 · Cited by 85
Self-citationStudies of mannose metabolism and effects of long-term mannose ingestion in the mouse
Davis, J. A., & Freeze, H. H. (2001) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(01)00183-0 · Cited by 84
Self-citationCongenital disorders involving defective N-glycosylation of proteins
Schachter, H. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000923 · Cited by 84
The congenital disorders of glycosylation: A multifaceted group of syndromes
Eklund, E. A., & Freeze, H. H. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.01.012 · Cited by 81
Self-citationThe Metabolic Origins of Mannose in Glycoproteins
Ichikawa, M., Scott, D. A., Losfeld, M., & Freeze, H. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.544064 · Cited by 79
Self-citationKjaergaard, S., KRISTIANSSON, B., Stibler, H., Freeze, H. H., Schwartz, M., Martinsson, T., & Skovby, F. (1998) · Acta Paediatrica · doi:10.1080/080352598750013680 · Cited by 75
Self-citationContinuous mannose infusion in carbohydrate‐deficient glycoprotein syndrome type I
Mayatepek, E., Schröder, M., Kohlmüller, D., Bieger, W., & Nützenadel, W. (1997) · Acta Paediatrica · doi:10.1111/j.1651-2227.1997.tb14825.x · Cited by 75
Carbohydrate-Deficient Glycoprotein Syndromes: Inborn Errors of Protein Glycosylation
Keir, G., WINCHESTER, B. G., & Clayton, P. T. (1999) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329903600103 · Cited by 75
Human Fibroblasts Prefer Mannose over Glucose as a Source of Mannose for N-Glycosylation
Panneerselvam, K., Etchison, J. R., & Freeze, H. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.37.23123 · Cited by 70
Self-citationWestphal, V., Peterson, S. M., Patterson, M. C., Tournay, A. E., Blumenthal, A. L., Treacy, E. P., & Freeze, H. H. (2001) · Genetics in Medicine · doi:10.1097/00125817-200111000-00003 · Cited by 66
Self-citationThe Importance of Being Dolichol
Krag, S. S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7828 · Cited by 66
Carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase-deficiency)
Carchon, H. A., SCHAFTINGEN, E. V., Matthijs, G., & Jaeken, J. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00073-3 · Cited by 66
Balancing N-linked glycosylation to avoid disease
Freeze, H. H., & Westphal, V. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01292-5 · Cited by 64
Self-citationRush, J. S., Panneerselvam, K., Waechter, C. J., & Freeze, H. H. (2000) · Glycobiology · doi:10.1093/glycob/10.8.829 · Cited by 63
Self-citationTowards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients
Freeze, H. H. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.01.004 · Cited by 63
Self-citationCline, A. E., Gao, N., Flanagan‐Steet, H. R., Sharma, V., Rosa, S., Sonon, R. N., Azadi, P., Sadler, K. C., Freeze, H. H., Lehrman, M. A., et al. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-05-0411 · Cited by 63
Self-citationMannose: a potential saccharide candidate in disease management
Dhanalakshmi, M., Sruthi, D., Jinuraj, K. R., Das, K., Dave, S., Andal, N. M., & Das, J. (2023) · Medicinal Chemistry Research · doi:10.1007/s00044-023-03015-z · Cited by 62
Nutritional Therapies in Congenital Disorders of Glycosylation (CDG)
Witters, P., Cassiman, D. M., & Morava, É. (2017) · Nutrients · doi:10.3390/nu9111222 · Cited by 60
Enzymatic assay of d-mannose in serum
Etchison, J. R., & Freeze, H. H. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.3.533 · Cited by 60
Self-citationEklund, E. A., Merbouh, N., Ichikawa, M., Nishikawa, A., Clima, J. M., Dorman, J. A., Norberg, T., & Freeze, H. H. (2005) · Glycobiology · doi:10.1093/glycob/cwj006 · Cited by 60
Self-citationMetabolism and Health Impacts of Dietary Sugars
Alam, Y. H., Kim, R., & Jang, C. (2022) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2022.11.1.20 · Cited by 59
Insights into complexity of congenital disorders of glycosylation
Goreta, S. Š., Dabelić, S., & Dumić, J. (2012) · Biochemia Medica · doi:10.11613/bm.2012.019 · Cited by 59
Thiesler, C. T., Cajic, S., Hoffmann, D., Thiel, C., van Diepen, L., Hennig, R., Sgodda, M., Weiβmann, R., Reichl, U., Steinemann, D., et al. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.054122 · Cited by 58
Analysis of Glycosylation in CDG-Ia Fibroblasts by Fluorophore-assisted Carbohydrate Electrophoresis
Gao, N., Shang, J., & Lehrman, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500510200 · Cited by 56
Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?
Witters, P., Honzík, T., Bauchart, E., Altassan, R., Pascreau, T., Bruneel, A., Vuillaumier‐Barrot, S., Séta, N., Borgel, D., Matthijs, G., et al. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0301-4 · Cited by 55
Freeze, H. H., & Aebi, M. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00072-1 · Cited by 55
Self-citationMarquardt, T., & Freeze, H. (2001) · Biological Chemistry · doi:10.1515/bc.2001.024 · Cited by 54
Self-citationA mouse model of a human congenital disorder of glycosylation caused by loss of PMM2
Chan, B., Clasquin, M. F., Smolen, G. A., Histen, G., Powe, J., Chen, Y., Lin, Z., Lu, C., Liu, Y., Cang, Y., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw085 · Cited by 53
Self-citationSharma, V., Ichikawa, M., He, P., Scott, D. A., Bravo, Y., Dahl, R., Ng, B. G., Cosford, N. D. P., & Freeze, H. H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.285502 · Cited by 51
Self-citationSone, H., Shimano, H., Ebinuma, H., Takahashi, A., Yano, Y., Iida, K., Suzuki, H., Toyoshima, H., Kawakami, Y., Okuda, Y., et al. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00153-7 · Cited by 51
Doerrler, W. T., & Lehrman, M. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13050 · Cited by 50
Fasting blood glucose levels in patients with different types of diseases
Zhang, Q., Zhao, G., Yang, N., & Zhang, L. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.01.004 · Cited by 50
Korner, C., Lehle, L., & von Figura, K. (1998) · Glycobiology · doi:10.1093/glycob/8.2.165 · Cited by 48
New and potential strategies for the treatment of PMM2-CDG
Gámez, A., Serrano, M., Gallego, D., Vilas, A., & Pérez, B. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129686 · Cited by 47
Treatment Options in Congenital Disorders of Glycosylation
Park, J. H., & Marquardt, T. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.735348 · Cited by 46
Gao, N., & Lehrman, M. A. (2002) · Glycobiology · doi:10.1093/glycob/12.5.353 · Cited by 46
Körner, C., Lehle, L., & FIGURA, K. V. (1998) · Glycoconjugate Journal · doi:10.1023/a:1006939104442 · Cited by 46
Ohkura, T., Fukushima, K., Kurisaki, A., Sagami, H., Ogura, K., Ohno, K., Hara‐Kuge, S., & Yamashita, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.6868 · Cited by 45
Hwang, J., Hernandez, J. M., Leduc, R., & Frost, S. C. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00109-9 · Cited by 43
Successful treatment of carbohydrate deficient glycoprotein syndrome type 1b with oral mannose
Hendriksz, C. J., McClean, P., Henderson, M. J., Keir, D. G., Worthington, V. C., Imtiaz, F., Schollen, E., Matthijs, G., & Winchester, B. G. (2001) · Archives of Disease in Childhood · doi:10.1136/adc.85.4.339 · Cited by 43
Carbohydrate-deficient glycoconjugate (CDG) syndromes: A new chapter of neuropaediatrics
Jaeken, J., & CASAER, P. (1997) · European Journal of Paediatric Neurology · doi:10.1016/s1090-3798(97)80015-3 · Cited by 40
Abnormal Metabolism of Mannose in Families with Carbohydrate-Deficient Glycoprotein Syndrome Type 1
Panneerselvam, K., Etchison, J. R., Skovby, F., & Freeze, H. H. (1997) · Biochemical and Molecular Medicine · doi:10.1006/bmme.1997.2599 · Cited by 40
Self-citationShanti, B., Silink, M., Bhattacharya, K., Howard, N. J., Carpenter, K. H., Fietz, M., Clayton, P. T., & Christodoulou, J. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-1180-2 · Cited by 37
Hardré, R., Khaled, A., Willemetz, A., Dupré, T., Moore, S. E. H., Gravier‐Pelletier, C., & Merrer, Y. L. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.09.074 · Cited by 35
Bernon, C., Carré, Y., Kuokkanen, E., Slomianny, M., Mir, A., Krzewinski, F., Cacan, R., Heikinheimo, P., Morelle, W., Michalski, J., et al. (2010) · Glycobiology · doi:10.1093/glycob/cwq169 · Cited by 33
Carbohydrate-deficient glycoprotein syndromes
Gordon, N. S. (2000) · Postgraduate Medical Journal · doi:10.1136/pmj.76.893.145 · Cited by 33
Cloning and characterization of human phosphomannomutase, a mammalian homologue of yeast SEC53
Hansen, S. H., Frank, S., & Casanova, J. E. (1997) · Glycobiology · doi:10.1093/glycob/7.6.829 · Cited by 33
Chemical Therapies for Congenital Disorders of Glycosylation
Sosicka, P., Ng, B. G., & Freeze, H. H. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00601 · Cited by 30
Self-citationGo, S., Sato, C., Furuhata, K., & Kitajima, K. (2006) · Glycoconjugate Journal · doi:10.1007/s10719-006-6734-z · Cited by 29
Therapeutic Monosaccharides: Looking Back, Moving Forward
Sosicka, P., Ng, B. G., & Freeze, H. H. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00565 · Cited by 28
Self-citationImmunometabolism regulates TCR recycling and iNKT cell functions
Fu, S., Zhu, S., Tian, C., Bai, S., Zhang, J., Zhan, C., Xie, D., Wang, L., Li, Z., Li, J., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aau1788 · Cited by 27
Metformin-stimulated Mannose Transport in Dermal Fibroblasts
Shang, J., & Lehrman, M. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310837200 · Cited by 27
Dietary mannose supplementation in phosphomannomutase 2 deficiency (PMM2-CDG)
Taday, R., Grüneberg, M., Chesne, I. D., Reunert, J., & Marquardt, T. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01528-z · Cited by 25
Therapies and therapeutic approaches in Congenital Disorders of Glycosylation
Thiel, C., & Körner, C. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-012-9447-5 · Cited by 24
Xu, G., Wong, M., Li, Q., Park, D., Cheng, Z., & Lebrilla, C. B. (2019) · Chemical Science · doi:10.1039/c9sc01653h · Cited by 24
Kondo, I., Mizugishi, K., Yoneda, Y., Hashimoto, T., Kuwajima, K., Yuasa, I., Shigemoto, K., & Kuroda, Y. (1999) · Clinical Genetics · doi:10.1034/j.1399-0004.1999.550109.x · Cited by 24
Witters, P., Edmondson, A. C., Lam, C. T., Johnsen, C., Patterson, M. C., Raymond, K., He, M., Freeze, H. H., & Morava, É. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01751-2 · Cited by 23
Self-citationYeast Models of Phosphomannomutase 2 Deficiency, a Congenital Disorder of Glycosylation
Lao, J. P., DiPrimio, N., Prangley, M. S., Sam, F. S., Mast, J. D., & Perlstein, E. O. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.118.200934 · Cited by 23
Congenital disorder of glycosylation Ic in patients of Indian origin
Newell, J. W., Seo, N., Enns, G. M., McCraken, M., Mantovani, J. F., & Freeze, H. H. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00089-1 · Cited by 22
Self-citationGlycosylation Changes as Markers for the Diagnosis and Treatment of Human Disease
Tong, L., Baskaran, G., Jones, M. B., Rhee, J. K., & Yarema, K. J. (2003) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2003.10648044 · Cited by 22
Human Glycosylation Disorders and Sugar Supplement Therapy
Freeze, H. H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9945 · Cited by 22
Self-citationUnsuccessful intravenous D-mannose treatment in PMM2-CDG
Grünert, S. C., Marquardt, T., Lausch, E. U., Fuchs, H. W., Thiel, C., Sutter, M., Schumann, A., Hannibal, L., & Spiekerkoetter, U. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1213-3 · Cited by 21
Congenital disorders of glycosylation: narration of a story through its patents
Monticelli, M., D’Onofrio, T., Jaeken, J., Morava, É., Andreotti, G., & Cubellis, M. V. (2023) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-023-02852-w · Cited by 21
Muus, U., Kranz, C., Marquardt, T., & Meier, C. (2004) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200300681 · Cited by 21
Budhraja, R., Radenkovic, S., Jain, A., Muffels, I. J. J., Ismaili, M. H. A., Kozicz, T., Pandey, A., & Morava, É. (2024) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2024.108487 · Cited by 20
Metadata
- Authors
- Panneerselvam, K., & Freeze, H. H.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Oregon Health & Science University (US)
- ORCID
- Freeze, H H
- Venue
- Journal of Clinical Investigation
- Published
- 1996-03-15
- Volume
- 97
- Issue
- 6
- Pages
- 1478-1487
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507208
- OpenAlex
- W2015514724
- Cited by
- 146
- References
- 57
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 9 · 2017: 2 · 2016: 5 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 5
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (R01 49096)
- National Institute of General Medical Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- congenital disorders of glycosylation, N-glycosylation, mannose, lipid-linked oligosaccharides, mannose-6-phosphate, mannose-1-phosphate, GDP-mannose, hexose transporters, fibroblasts, glycoprotein synthesis, congenital disorders
- MeSH terms
- Cell Line, Fibroblasts, Glycosylation, Humans, Mannose, Oligosaccharides, Congenital Disorders of Glycosylation, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.